REG - GSK PLC - GSK publishes Annual Report 2022

GSKAnnouncement

10/03/2023 10:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230310:nRSJ5978Sa&default-theme=true

RNS Number : 5978S  GSK PLC  10 March 2023

 

GSK plc

(the 'Company')

 

Publication of Annual Report 2022

 

 

The Company has today published on its website www.annualreport.gsk.com its
Annual Report for the year ended 31 December 2022 ('Annual Report 2022').

 

In compliance with Listing Rule 9.6.1R of the UK Financial Conduct Authority
('FCA'), the Annual Report 2022 has been submitted to the FCA's National
Storage Mechanism ('NSM') and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

A hard copy version of the Annual Report 2022 and the Notice of Annual General
Meeting 2023 ('AGM Notice') will be sent to those shareholders who have
elected to receive paper communications on or around 27 March 2023. The AGM
Notice will be made available to shareholders who have not elected to receive
paper communications on the same date.

 

This announcement is not a substitute for reading the Annual Report 2022 in
full.

 

Additional Information

 

For the purposes of complying with the FCA's Disclosure and Transparency Rules
('DTRs') and the requirements imposed on issuers through the DTRs, information
required to be communicated with the media in unedited full text was included
in the Annual Report 2022. The Annual Report 2022 was submitted to the NSM and
will shortly be available for inspection. It is also available on the
Company's website as noted above.

 

This announcement is made in accordance with DTR 6.3.5R(1A).

 

V A Whyte

Company Secretary

 

10 March 2023

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSEAEDEFDSDEFA